Annual Working Capital
$400.56 M
+$189.58 M+89.86%
December 31, 2024
Summary
- As of March 2, 2025, TRDA annual working capital is $400.56 million, with the most recent change of +$189.58 million (+89.86%) on December 31, 2024.
- During the last 3 years, TRDA annual working capital has risen by +$108.58 million (+37.19%).
- TRDA annual working capital is now at all-time high.
Performance
TRDA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$400.56 M
+$5.83 M+1.48%
December 31, 2024
Summary
- As of March 2, 2025, TRDA quarterly working capital is $400.56 million, with the most recent change of +$5.83 million (+1.48%) on December 31, 2024.
- Over the past year, TRDA quarterly working capital has dropped by -$3.17 million (-0.79%).
- TRDA quarterly working capital is now -0.79% below its all-time high of $403.73 million, reached on June 30, 2024.
Performance
TRDA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TRDA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.9% | -0.8% |
| 3 y3 years | +37.2% | +113.2% |
| 5 y5 years | +2481.6% | +113.2% |
TRDA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.2% | -0.8% | +113.2% |
| 5 y | 5-year | at high | +2481.6% | -0.8% | +994.7% |
| alltime | all time | at high | +2481.6% | -0.8% | +994.7% |
Entrada Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $400.56 M(+89.9%) | $400.56 M(+1.5%) |
| Sep 2024 | - | $394.73 M(-2.2%) |
| Jun 2024 | - | $403.73 M(+68.1%) |
| Mar 2024 | - | $240.23 M(+13.9%) |
| Dec 2023 | $210.97 M(+12.3%) | $210.97 M(-3.0%) |
| Sep 2023 | - | $217.61 M(-17.7%) |
| Jun 2023 | - | $264.25 M(-7.8%) |
| Mar 2023 | - | $286.54 M(+52.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $187.90 M(-35.6%) | $187.90 M(-11.9%) |
| Sep 2022 | - | $213.18 M(-9.6%) |
| Jun 2022 | - | $235.83 M(-8.3%) |
| Mar 2022 | - | $257.29 M(-11.9%) |
| Dec 2021 | $291.98 M(+698.0%) | $291.98 M(+150.9%) |
| Sep 2021 | - | $116.37 M(-12.6%) |
| Jun 2021 | - | $133.10 M(+263.8%) |
| Dec 2020 | $36.59 M(+135.8%) | $36.59 M |
| Dec 2019 | $15.52 M | - |
FAQ
- What is Entrada Therapeutics annual working capital?
- What is the all time high annual working capital for Entrada Therapeutics?
- What is Entrada Therapeutics annual working capital year-on-year change?
- What is Entrada Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly working capital year-on-year change?
What is Entrada Therapeutics annual working capital?
The current annual working capital of TRDA is $400.56 M
What is the all time high annual working capital for Entrada Therapeutics?
Entrada Therapeutics all-time high annual working capital is $400.56 M
What is Entrada Therapeutics annual working capital year-on-year change?
Over the past year, TRDA annual working capital has changed by +$189.58 M (+89.86%)
What is Entrada Therapeutics quarterly working capital?
The current quarterly working capital of TRDA is $400.56 M
What is the all time high quarterly working capital for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly working capital is $403.73 M
What is Entrada Therapeutics quarterly working capital year-on-year change?
Over the past year, TRDA quarterly working capital has changed by -$3.17 M (-0.79%)